EMILY FULK: Open Payments
NPI 1427831585 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,404 in 151 payments from 20 companies in 2025. Trend: 2023 $407 · 2024 $2,933 · 2025 $3,404
Food & beverage: $3,404
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $534 |
| Axsome Therapeutics, Inc. | 17 | $427 |
| AstraZeneca Pharmaceuticals LP | 12 | $378 |
| Aimmune Therapeutics, Inc. | 10 | $330 |
| Lilly USA, LLC | 12 | $279 |
| Phathom Pharmaceuticals, Inc. | 22 | $222 |
| E.R. Squibb & Sons, L.L.C. | 16 | $175 |
| Dexcom, Inc. | 5 | $160 |
| Boston Scientific Corporation | 1 | $150 |
| ABBVIE INC. | 8 | $141 |
Products named: Auvelity, ZENPEP, ELIQUIS, VOQUEZNA, Wegovy, AIRSUPRA, Dexcom G6 Transmitter, WATCHMAN Access System.
Industry payments across WI — which companies pay providers there.
